| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | WO1996010414A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | WO1996010401A1 Methods for regulation of insulin-like growth factor i receptor |
| 04/11/1996 | WO1996010400A1 Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses |
| 04/11/1996 | WO1996010390A1 Novel compositions for the introduction of polyanionic materials into cells |
| 04/11/1996 | WO1996010335A1 Use of polyols for improving the introduction of genetic material into cells |
| 04/11/1996 | WO1996006935A3 Arabinoxylan degrading enzymes |
| 04/11/1996 | WO1996006171A3 New polypetides having a toxic activity against insects of the dipterae family |
| 04/11/1996 | WO1996005866A3 Live vaccine for the treatment of tumour diseases |
| 04/11/1996 | EP0733125A4 A representational approach to dna analysis |
| 04/11/1996 | CA2201748A1 Genes encoding signal recognition particle of aspergillus niger |
| 04/11/1996 | CA2201588A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 04/11/1996 | CA2201506A1 Novel protein marker and dna encoding same |
| 04/11/1996 | CA2201474A1 The irs family of genes |
| 04/11/1996 | CA2201428A1 Mycobacterial reporter strains and uses thereof |
| 04/11/1996 | CA2201353A1 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 04/11/1996 | CA2201315A1 Direct introduction of foreign materials into cells |
| 04/11/1996 | CA2201302A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 04/11/1996 | CA2201281A1 Human alpha 4 receptor subunit of the gaba-a receptor |
| 04/11/1996 | CA2201119A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | CA2200629A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | CA2174944A1 Cloned dna polymerases from thermotoga neapolitana and mutants thereof |
| 04/10/1996 | EP0705905A2 Method for the sensitive detection of nucleic acids |
| 04/10/1996 | EP0705904A1 Luminescent nitrifying microorganisms |
| 04/10/1996 | EP0705903A1 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene |
| 04/10/1996 | EP0705902A1 17q-Linked breast and ovarian cancer susceptibility gene |
| 04/10/1996 | EP0705901A2 Method of separating recombinant pro-factor IX from recombinant factor IX |
| 04/10/1996 | EP0705844A1 Gene encoding cationic amino acid transporter protein |
| 04/10/1996 | EP0705436A1 Method for the diagnosis and analysis of breast carcinoma |
| 04/10/1996 | EP0705435A1 A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom |
| 04/10/1996 | EP0705349A1 Parallel primer extension approach to nucleic acid sequence analysis |
| 04/10/1996 | EP0705346A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 04/10/1996 | EP0705344A1 Adenovirus vectors for gene therapy |
| 04/10/1996 | EP0705343A1 Synthetic antifungal peptides |
| 04/10/1996 | EP0705342A1 Methods and compositions for modulating lipid content of plant tissues |
| 04/10/1996 | EP0705341A1 Hybrid receptor molecules |
| 04/10/1996 | EP0705340A1 Toxin gene from xenorhabdus nematophilus |
| 04/10/1996 | EP0705339A1 Human cell adhesion protein aamp-1 and uses thereof |
| 04/10/1996 | EP0705338A1 Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s) |
| 04/10/1996 | EP0705337A1 Clostridium bifermentans dna fragment bearing genes coding for proteins linked to an insecticidal activity |
| 04/10/1996 | EP0705336A1 Test and model for polycystic ovary syndrome and male pattern baldness |
| 04/10/1996 | EP0705335A1 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 04/10/1996 | EP0705334A1 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 04/10/1996 | EP0705333A1 Transgenic production of ec-sod |
| 04/10/1996 | EP0705332A1 Construction and use of synthetic constructs encoding syndecan |
| 04/10/1996 | EP0705278A1 Apoptose inhibitor |
| 04/10/1996 | EP0705277A1 Prostaglandin receptor ep3 and dna encoding it |
| 04/10/1996 | EP0705276A1 Prostaglandin receptor fp and dna encoding it |
| 04/10/1996 | EP0705271A1 Hybridization and sequencing of nucleic acids |
| 04/10/1996 | EP0705270A1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 04/10/1996 | EP0649429A4 Heteroatomic oligonucleoside linkages. |
| 04/10/1996 | EP0616638B1 Method and device for the isolation of cell components, such as nucleic acids, from natural sources |
| 04/10/1996 | EP0537148B1 Purification of human interleukin-4 secreted from an escherichia coli mutant |
| 04/10/1996 | EP0494135B1 Human "neu" related protein p100 and use of the same for detecting preneoplastic or neoplastic cells in a human |
| 04/10/1996 | EP0415978B1 Dna-analysis method involving gene amplification and magnetic particles |
| 04/10/1996 | EP0387286B1 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 04/10/1996 | CN1120353A Anti-microbial agents and screening method therefor |
| 04/10/1996 | CN1120352A Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 04/10/1996 | CN1120351A An alpha-galactosidase enzyme |
| 04/09/1996 | US5506350 In presence of a trifluoroacetate chaotrope |
| 04/09/1996 | US5506344 Antibodies specific for BCL-2 gene product |
| 04/09/1996 | US5506343 Antibodies specific for the DF3 carcinoma associated antigen |
| 04/09/1996 | US5506212 Oligonucleotides with substantially chirally pure phosphorothioate linkages |
| 04/09/1996 | US5506205 Treatment of diabetes |
| 04/09/1996 | US5506202 Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing them |
| 04/09/1996 | US5506139 Vaccines, immunology |
| 04/09/1996 | US5506138 Recombinant vaccinia virus encoding cytochromes P-450 |
| 04/09/1996 | US5506135 Fab fragment, having specificities against fibrin and thrombolytic substances |
| 04/09/1996 | US5506134 Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex |
| 04/09/1996 | US5506133 Polypeptide |
| 04/09/1996 | US5506132 Monoclonal antibodies or binding fragments thereof |
| 04/09/1996 | US5506131 Immortalized human cell lines containing exogenous cytochrome P450 genes |
| 04/09/1996 | US5506128 Recombinant infectious bovine rhinotracheitis virus |
| 04/09/1996 | US5506126 Diagnosis, therapy antigen |
| 04/09/1996 | US5506125 Apparatus for acceleration of carrier particles into a target organism |
| 04/09/1996 | US5506121 Fusion peptides with binding activity for streptavidin |
| 04/09/1996 | US5506120 Method of producing peptides or proteins as fusion proteins |
| 04/09/1996 | US5506119 DNA encoding variant CD44 surface proteins associated with metastatic tumors |
| 04/09/1996 | US5506118 Method of using eukaryotic expression vectors comprising a poly GT element in the presence of trans-acting gene products |
| 04/09/1996 | US5506107 Selecting ligand agonists and antagonists |
| 04/09/1996 | US5506106 Methods of detecting micrometastasis of prostate cancer |
| 04/09/1996 | US5506103 Method for detecting charged oligonucleotides in biological fluids |
| 04/09/1996 | US5506102 Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription |
| 04/09/1996 | US5506101 Detecting alteration of wild-type mitochondrial ribosomal rna associated with said deafness; complication of using aminoglycoside antibiotics; screening patients |
| 04/09/1996 | US5506098 Adding probe complex comprising protein bound to reporter-labeled probe to allow complex to contact duplex dna target and bind to target, removing unbound complex |
| 04/09/1996 | US5505947 Attenuating mutations in Venezuelan Equine Encephalitis virus |
| 04/09/1996 | US5505943 Compositions containing protease produced by vibrio and method of use in debridement and wound healing |
| 04/09/1996 | US5505941 Inoculating host with synthetic genetic engineered pathogen |
| 04/07/1996 | CA2159958A1 New toxoplasma gondii antigens |
| 04/07/1996 | CA2159957A1 Regulated genes by stimulation of chondrocytes with il-1.beta. |
| 04/06/1996 | CA2140057A1 Chromosome 18q loss and prognosis in colorectal cancer |
| 04/05/1996 | CA2159700A1 Method for the separation of recombinant pro-factor ix from recombinant factor ix |
| 04/04/1996 | WO1996020276A1 Tissue specific hypoxia regulated therapeutic constructs |
| 04/04/1996 | WO1996010182A1 Cell tests and diagnostic index for alzheimer's disease |
| 04/04/1996 | WO1996010088A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 04/04/1996 | WO1996010086A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 04/04/1996 | WO1996010085A1 PROCESS OF PRODUCING β-LACTAM ANTIBIOTICS APPLYING MICROORGANISMS WITH INCREASED LIGASE ACTIVITY |
| 04/04/1996 | WO1996010084A1 Process for the production of secondary metabolites |
| 04/04/1996 | WO1996010083A1 Novel pesticidal proteins and strains |
| 04/04/1996 | WO1996010082A1 Yeast with modified permeability |